JNJ0966 is primarily utilized in research settings as a selective inhibitor targeting specific enzymes or pathways involved in disease mechanisms. It is particularly studied for its potential role in neurodegenerative disorders, where it may help modulate protein aggregation or inflammation. Additionally, JNJ0966 is explored in cancer research for its ability to interfere with signaling pathways that promote tumor growth. Its application extends to preclinical studies aimed at understanding cellular processes and developing targeted therapies for complex diseases.